baber/WOPTO huggingface dataset:
Patent CA-2563571-A1 (CA)
Title: Aircraft with a fluid-duct-system
Inventor: MEISTER JUERGEN
IPC: F15D1/12
Filed: 2005-05-11
Abstract: An aircraft with a fluid-duct system for extraction of the laminar layer and/or blowing out of fluid at vulnerable places of the outer skin, wherein the fluid-duct system (26, 19, 18) by means of switchable valves (6, 4) is connectable to a pump facility (3), which is driven by the exhaust air from the cabin for generating a reduced pressure for the extraction of the laminar layer.
Patent CA-2564568-A1 (CA)
Inventor: KINET JEAN-PIERRE
IPC: A61K31/421
Filed: 2005-04-19
Abstract: The present invention relates to a method for treating inflammatory muscle disorders including myositis and muscular dystrophy comprising administering a compound capable of depleting mast cells or a compound inhibiting mast cell degranulation, to a human in need of such treatment. Such compounds can be chosen from c-kit inhibitors and more particularly non-toxic, selective and potent c-kit inhibitors. Preferably, said inhibitor is unable to promote death of IL-3 dependent cells cultured in presence of IL-3.
Patent CA-2566002-A1 (CA)
Title: Systeme alternatif de repartition d'air
Inventor: DISTASO CHRIS
IPC: F04B43/073
Filed: 2005-05-09
Abstract: Il est prévu un système alternatif de répartition d~air englobant une boîte de distribution montée sur un collecteur d~air. Le logement de valve comprend un cylindre avec un élément de valve dans le cylindre. Une garniture non métallique de matériau isolant thermiquement et d~une certaine épaisseur se trouve entre la boîte de distribution et le collecteur d~air.
Patent CA-2569235-A1 (CA)
Title: Anti-ghrelin antibodies
Inventor: WITCHER DERRICK RYAN
IPC: C07K14/60
Filed: 2005-07-06
Abstract: Monoclonal antibodies, including humanized antibodies, which bind acylated and unacylated human ghrelin are disclosed. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies of the invention are useful for neutralizing ghrelin activity, e.g., in a human subject suffering from a disorder in which ghrelin activity is detrimental.  Nucleic acids, vectors and host cells for expressing the recombinant anti-ghrelin antibodies are also encompassed by the invention.
Patent CA-2572430-A1 (CA)
Inventor: MAK JOHN
IPC: F25J3/00
Filed: 2005-06-22
Abstract: A gas condensate production plant comprises a plurality of separation units in which C2 and/or C3 lighter components are stripped from the separator feeds using compressed heated stripping vapor produced from the feed in respective downstream separation units. Contemplated plants substantially reduce heating and cooling duties by using the waste heat from the compressor discharges in the separation process. Furthermore, the multi-stage fractionation according to the inventive subject matter provides improved gas condensate recovery at reduced energy costs.
Patent CA-2574354-A1 (CA)
Title: Imidazole and thiazole derivatives as antiviral agents
Inventor: CONTE IMMACOLATA
IPC: A61K45/06
Filed: 2005-07-14
Abstract: The present invention relates to compounds of the formula (I), wherein R1, R2, A, B, D, E, F, G and Ar are as defined herein, and pharmaceutically acceptable salts thereof, useful in the prevention and treatment of hepatitis C  infections.
Patent CA-2574627-A1 (CA)
Title: Compositions for treatment of inflammation and pain using a combination of a cox-2 selective inhibitor and a ltb4 receptor antagonist
Inventor: PATEL PHENIL JAYANTILAL
IPC: A61K45/06
Filed: 2005-07-11
Abstract: The present invention provides a therapeutic composition comprising a COX-2 selective inhibitor or a prodrug thereof and an LTB4 receptor antagonist. A  method is provided for the use of such composition in the treatment, prevention, or inhibition of inflammation, an inflammation-related disorder, pain, or a pain-related disorder.
Patent CA-2575059-A1 (CA)
Title: Pharmaceutical compositions comprising cilobradine
Inventor: DAEMMGEN JUERGEN
IPC: A61P9/00
Filed: 2001-04-07
Abstract: The present invention relates to pharmaceutical compositions comprising cilobradine and a cardioactive compound selected from a cardioglycoside, a vasodilator, an angiotensin converting enzyme inhibitor and an angiotensin-II antagonist. In a preferred composition, the angiotensin-II antagonist is telmisartan.
Patent CA-2576881-A1 (CA)
Title: Permutation data transform to enhance security
Inventor: RIJMEN VINCENT
IPC: H04K1/04
Filed: 2005-08-09
Abstract: One data transformation permutes certain bits in a data input (1005) based on other bits in the data input (1030). Another data transformation raises one segment of a data input (1120) to a power of a function of another segment, the power being relatively prime to a function of a predefined modulus (1115).  The modulus is then applied to the result (1125), and the transformed data assembled (113). In one key derivation application, a segment of the master key is hashed (1415). Two numbers are derived from another segment of the master key (1420). A universal hash function is applied to the result (1430) of the hash, from which bits are selected as the derived key (1435). In another embodiment, an encoded counter is combined with segments (1510) of the master key. The result is then hashed (1520), from which bits are selected as the derived key (1525).
Patent CA-2577181-A1 (CA)
Title: Heteroaroyl-substituted serine amides utilized as herbicides
Inventor: SIEVERNICH BERND
IPC: C07D405/12
Filed: 2005-09-14
Abstract: The invention relates to heteroaroyl-substituted serine amides of formula (I), wherein the variables A, Het, and R1 to R5 have the meanings indicated in the description, the agriculturally useful salts thereof, methods and intermediate products for manufacturing the same, and the use of said compounds or agents containing said compounds for controlling unwanted plants.
Patent CA-2586341-A1 (CA)
Title: Systeme et methode pour essai d'integrite en cours de fabrication d'un filtre
Inventor: RIESE STEFAN
IPC: B01D35/143
Filed: 2007-04-26
Abstract: L'invention concerne une méthode de vérification de l'intégrité d'un filtre en cours d'utilisation. La méthode peut comprendre les étapes de : coupler une source gazeuse à une entrée du filtre (202) sans retirer le filtre d'un système de distribution, la source gazeuse fournissant un gaz (22) et régulant la pression du gaz; coupler un tube (204) à une sortie d'un filtre (202), le tube étant rempli avec un liquide (20); augmenter la pression tout en contrôlant le tube (204), à l'aide d'un faisceau lumineux (21), pour détecter le déplacement du liquide (20' par une bulle de gaz ou plus (23); et déterminer la valeur de la pression où le déplacement du liquide (20) est détecté.
Patent CA-2587005-A1 (CA)
Title: Method and apparatus for a hub in daisy chain configuration
Inventor: NICHOLS GLEN WILLIAM
IPC: H04L12/42
Filed: 2004-12-17
Abstract: A connector hub comprising a number of cable interfaces is used to allow a number of network devices connected to a network to be connected in a free-form manner, yet still maintain a daisy chain configuration. A cable comprising at least two conductors, wherein the conductors are preferably a twisted pair of copper wire, is used to connect each of the network devices to a cable interface an the connector hub, so that each network device only has a single cable connected to it. The connector hub connects a master or primary network device to the network devices connected by a cable to the cable interfaces of the connector in a daisy chain configuration.
Patent CA-2589483-A1 (CA)
Title: Substituted piperazines as cb1 antagonists
Inventor: WEINSTEIN JAY
IPC: A61K31/496
Filed: 2005-12-01
Abstract: Compounds of Formula (I): Chemical formula should be inserted here as it appears on the abstract in paper form. or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
Patent CA-2593371-A1 (CA)
Title: System and method for on-call scheduling
Inventor: HAKMEH ASSEM
IPC: G16H40/20
Filed: 2007-06-25
Abstract: The invention consists of a method of scheduling work shifts for medical personnel at multiple locations, comprising the steps of: a) collecting shift preference information, including non-working dates, from each member of the personnel to be scheduled for shifts at the locations in a pre-defined shift period; b) defining a set of rules to apply to shifts and schedules; c) applying a scheduling algorithm based on the defined rules in combination with the collected shift preference information to create a shift schedule for all personnel covering the shift period; d) submitting the shift schedule for approval by a human administration; and e) enabling modifications to the approved shift schedule by administration and personnel, including exchange of scheduled shifts by the personnel.
Patent CA-2594052-A1 (CA)
Title: System and method for managing hardware configuration parameters
Inventor: MAILLOUX JERRY
IPC: G06F9/445
Filed: 2007-07-31
Abstract: A system and method manages configuration data within a hardware component of a device to support hardware component changes during development or manufacture of the device. A Standardized Virtual Part (SVP) file is formed as a binary file and includes a SVP header that comprises metadata of one of at least schema version, revision numbers, part numbers, creator and description. The SVP file also includes hardware configuration data and a SVP trailer that includes error checking data for data authentication. The SVP file is loaded onto the device during development or manufacture for configuring the hardware component.
Patent CA-2595046-A1 (CA)
Title: Color interlayer film for laminated glass, and laminated glass
Inventor: MARUMOTO TADASHI
IPC: C09J129/14
Filed: 2006-02-02
Abstract: A colored intermediate film for a laminated glass which is formed from a resin composition containing a poly(vinyl acetal) resin, a coloring agent and an agent for shielding an infrared ray, characterized in that the resin composition further comprises a phosphoric acid ester compound in an amount of 5 parts by weight or less relative to 100 parts by weight of the poly(vinyl acetal) resin; and a laminated glass using the colored intermediate film. The above colored intermediate film for a laminated glass is excellent in the infrared ray shielding property and is free from the whitening thereof even when the film absorbs moisture, while retaining the basic performance capability as an intermediate film for a laminated glass.
Patent CA-2597385-A1 (CA)
Inventor: MCKAY ALBERT A
IPC: F16L13/14
Filed: 2006-02-13
Abstract: A fitting for making connections with a pipe includes a coupling body having an inside surface defining a bore for receiving a pipe. A ring is fitted over the coupling body for sealing and mechanically connecting the coupling body to the pipe. An axisymmetrical main seal is formed on the inside surface of the coupling body that seals and connects to the pipe when the ring is installed on the coupling body. An axisymmetrical inboard seal is formed on the inside surface of the coupling body axially spaced from the main seal that seals and connects to the pipe when the ring is installed on the coupling body. At least one of the coupling body and the ring' is configured so that the inboard seal seals and connects after the main seal seals and connects to the pipe. An axisymmetrical outboard seal is formed on the inside surface of the coupling body axially spaced from the main seal that connects to the pipe when the ring is installed on the coupling body. At least one of the coupling body and the ring is further configured so that the outboard seal seals and mechanically connects after the inboard seal seals and connects to the pipe. At least one of the coupling body and the ring is still further configured to apply a restoring load to the main seal to further seal and mechanically connect the main seal to the pipe after the outboard seal seals and connects to the pipe.
Patent CA-2597501-A1 (CA)
Inventor: TWOHIG VICTOR
IPC: B65D49/02
Filed: 2006-02-10
Abstract: A container closure (1) for mousing on a container (2) is disclosed, the container being of the type comprising a container body (4) In fluid communication with a bored container opening (8) for the delivery of liquid from the interior of the container (2). The ctasure (1) comprises m bored closure body (8) having a closure outlet (10) at one end and a closure intet (12) at the other end. The closure body (8) mounts a plurality of exterior ribs (14) for engagement with the Interior walls of the container opening (6).  The closure (1) is particularly advantageous as it will prevent the entry of liquid or otter contaminants Into the container (2), in addition to enabling air to flow into the container (2) during drinking which will prevent the formation of a vacuum within the container.
Patent CA-2601628-A1 (CA)
Title: Certain substituted amides, method of making, and method of use thereof
Inventor: LEE SEUNG H
IPC: A61K31/4985
Filed: 2006-03-09
Abstract: At least one chemical entity chosen from compounds of Formula (2) and pharmaceutically acceptable salts, solvates, chelates, non-covalent complexes, prodrugs, and mixtures thereof is described herein. Pharmaceutical compositions comprising at least one chemical entity of the invention, together with at least one pharmaceutically acceptable vehicle chosen from carriers adjuvants, and excipients, are described. Methods of treating patients suffering from certain diseases responsive to inhibition of Btk activity and/ or B-cell activity are described. Methods for determining the presence of Btk in a sample are described.
Patent CA-2603393-A1 (CA)
Inventor: LIPPY STEVEN A
IPC: G03F7/42
Filed: 2006-03-13
Abstract: L'invention concerne une composition de décapage et de nettoyage FEOL (front end of the line: d'entrée de ligne) permettant de décaper et d'éliminer une photorésine non brûlée sur une tranche de substrat, cette composition comprenant: a) au moins un solvant de décapage organique, b) des ions fluorure comprenant au moins un des composés suivants: fluorure d'ammonium, bifluorure d'ammonium et fluorure d'hydrogène, c) au moins un agent acidifiant choisi parmi les acides inorganiques ou les acides organiques, et d) de l'eau, cette composition pouvant en outre éventuellement comprendre un agent d'oxydation.
Patent CA-2607227-A1 (CA)
Title: (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
Inventor: GOBBI LUCA CLAUDIO
IPC: A61K31/517
Filed: 2006-04-24
Abstract: The present invention relates to compounds of formula (I) wherein R1 is hydrogen, lower alkyl, lower alkoxy, halogen or lower alkyl substituted by halogen; R is hydrogen or halogen; or R1 and R are together with the carbon atom to which they are attached -CH=CH-CH=CH-; R2 is hydrogen, lower alkyl, phenyl optionally substituted by halogen, or is hetaryl, optionally substituted by lower alkyl; R3 is hydrogen, lower alkyl, phenyl, benzyl, lower alkenyl, lower alkoxy, phenyloxy, benzyloxy, S-lower alkyl, halogen, CN, lower alkyl substituted by halogen or O-lower alkyl substituted by halogen; R4 is hydrogen or lower alkyl, aryl is phenyl or naphthyl; n is 1, 2 or 3; m is 1 or 2; and pharmaceutically acceptable acid addition salts and tautomeric forms thereof. It has been found that the compounds of formula I have a good activity on the 5-HT5A receptor. Therefore, the invention provides the use of a compound of formula I or a pharmaceutically acceptable salt thereof for the manufacture of medicaments for the treatment of certain CNS disorders.
Patent CA-2608012-A1 (CA)
Title: Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
Inventor: ROCHER JEAN-PHILIPPE
IPC: A61K31/4245
Filed: 2006-05-17
Abstract: The present invention relates to new compounds which are Oxadiazole derivatives of formula (I) wherein B, P, Q,W, R1 and R2 are defined in the description. Invention compounds are useful in the prevention or treatment of central or peripheral nervous system disorders as well as other disorders modulated by mGluR5 receptors.
Patent CA-2608461-A1 (CA)
Title: Method for formatting digital broadcast transport stream packet for improved receiving performance, digital broadcast transmitter, and signal processing method thereof
Inventor: JUNG CHOON-SIK
IPC: H04N7/24
Filed: 2006-05-19
Abstract: A method of formatting a digital broadcast transport stream packet, a digital broadcast transmitter, and a signal processing method thereof, includes constructing a transport stream packet that includes a stuffing region for an insertion of a known supplementary reference s equence (SRS) data therein, randomizing the packet that includes the stuffing region is randomized, and the SRS data is inserted into the stuffing region of the randomized packet.  Adding a parity for an error correction to the packet into which the SRS data has been inserted, the packet to which the parity has been added is interleaved, and a trellis encoding of the interleaved packet is performed.  Inserting a segment sync signal and a field sync signal into the trellis-encoded packet, and a vestigial side band (VSB) modulation and an RF  conversion of the packet are performed to transmit the VSB-modulated and RF-converted packet.
Patent CA-2609948-A1 (CA)
Title: Vasoactive kit and composition and uses thereof
Inventor: EINI MEIR
IPC: A61K31/203
Filed: 2006-05-08
Abstract: The present invention relates to a therapeutic kit to provide a safe and effective dosage of a vasoactive agent, including an aerosol packaging assembly including: a container accommodating a pressurized product; and an outlet capable of releasing the pressurized product as a foam, wherein the pressurized product comprises a foamable composition including: a vasoactive agent; at least one organic carrier selected from the group consisting of a hydrophobic organic carrier, an organic polar solvent, an emollient and mixtures thereof, at a concentration of about 2% to about 50% by weight, a surface- active agent, about 0.01% to about 5% by weight of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent, water; and liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.
Patent CA-2612533-A1 (CA)
Inventor: LEE CHING-PANG
IPC: F01D5/14
Filed: 2007-11-28
Abstract: A trailing edge vortex reducing system (11) includes a gas turbine engine airfoil (39) extending in a spanwise direction (SD), one or more spanwise extending plasma generators (2) in a trailing edge region (89) around a trailing edge (TE) of the airfoil (39). The plasma generators (2) may be mounted on an outer wall (26) of the airfoil (39) with first and second pluralities of the plasma generators (2) on pressure and suction sides (46, 48) of the airfoil (39) respectively. The plasma generators (2) may include inner and outer electrodes (3, 4) separated by a dielectric material (5) disposed within a grooves (6) in an outer hot surface (54) of the outer wall (26) of the airfoil (39). The plasma generators (2) may be located at an aft end of the airfoil (39) and the inner electrodes (3) flush with the trailing edge base (34). A  method for operating the system (11) includes energizing one or more of plasma generators (2) in steady state or unsteady modes.
Patent CA-2613334-A1 (CA)
Title: Extraction device having a centrifugal separator
Inventor: ASAL WOLFGANG
IPC: B04C9/00
Filed: 2006-06-27
Abstract: In an extraction device comprising a suction apparatus (16) with an electric motor (32) and an centrifugal separator (14) exhibiting an inlet cylinder (22) , a vertically arranged dip pipe (30) and a lateral suction nozzle (24) through which a laden gas stream enters the inlet cylinder (22) , it is provided with a view to creating a low-cost and easy-to-handle extraction device of a compact design, having a centrifugal separator, that the electric motor (32) is arranged inside the dip pipe (30) .
Patent CA-2613913-A1 (CA)
Inventor: GREHANT BERNARD
IPC: E06B9/68
Filed: 2007-12-11
Abstract: A method for setting a safety threshold that triggers the sending, by an acceleration or movement sensor device (20), of a safety signal that causes a safety movement of a motorised screen (11) used as a closure or as a sunshade or for privacy, said method comprising the following steps: - manual shaking of the screen, - recording of a signal produced by a sensor means (33) during the manual shaking step, and - determination of the safety threshold from this recording.
Patent CA-2614944-A1 (CA)
Inventor: GOTO KUNIO
IPC: F16L15/00
Filed: 2002-04-11
Abstract: A threaded joint for steel pipes comprising a pin and a box each having a contact surface including a threaded portion and an unthreaded metal contact portion, characterized in that the contact surface of at least one of the pin and the box has a solid lubricant coating formed thereon which comprises a lubricating powder, ultraviolet screening fine particles, and a resin, wherein the ultraviolet fine particles are fine particles of one or more substances selected from titanium oxide, zinc oxide, and iron oxide.
Patent CA-2616952-A1 (CA)
Title: Rolling mill with stands with three adjustable rolls
Inventor: MARINI FABRIZIO
IPC: B21B31/10
Filed: 2006-07-28
Abstract: The invention relates to a rolling mill for tubes, in which a series of roll-holder containers (10) is housed in an external structure (2) extended along a rolling axis (L); the containers can slide inside the structure to be extracted therefrom and each one houses at least three rolls (17, 18, 19) controlled by respective driving motors (41, 42, 43). In accordance with the intervention the rolls (17, 18, 19) can be moved inside the containers (10) in a guided way along directions radial in relation to the rolling axis, in order to regulate the distance therefrom.
Patent CA-2618910-A1 (CA)
Inventor: MILANO ARTHUR JOHN JR
IPC: E04H15/60
Filed: 2008-01-24
Abstract: An intercoupled piping assembly comprising a first elongated pipe; a second elongated pipe; a coupler for coupling the first elongated pipe to the second elongated pipe and a securing assembly comprising an elongated member that extends through an aperture in the first elongated pipe, through an aperture in the coupler and through an aperture in the second elongated pipe and a securing member for ensuring the first elongated pipe, the second elongated pipe and the coupler remain coupled together by at least in part the elongated member, whereby the first and second elongated pipes are intercoupleable via the coupler and are resisted from shifting from their orthogonal alignment due to their respective coupling to the coupler.
Patent CA-2619961-A1 (CA)
Title: Variable diameter filaments
Inventor: BREZLER RUSSEL A
IPC: A46B9/04
Filed: 2006-09-01
Abstract: The present invention discloses filaments with varying diameter along its length. This variation in diameter along the length of the filaments, when assembled into a toothbrush tuft improves both the interproximal cleaning and the scrubbing effectiveness of the toothbrush.